Over the last 15 months, at least 103 patients have died after receiving heparin blood-thinning medication, according to information released Tuesday by the U.S. Food and Drug Administration. In February 2008, Baxter Healthcare Corporation recalled multi-dose and single-dose vials of heparin sodium for injection after FDA scientists identified a previously unknown contaminant in the heparin. To ensure that all is being done to provide a safe supply of heparin, FDA is urging medical device manufacturers to screen for the potentially harmful contaminant. The Los Angeles Times reports that “products to be tested cover a spectrum of equipment and uses,” including “kits that flush out intravenous lines, drug-coated stents for opening clogged arteries and certain diagnostic tests that use heparin and could deliver inaccurate results if contaminated.”
- Information on Adverse Event Reports and Heparin (FDA)
- Concerns Widen Over Blood Thinner from China (L.A. Times)
- More Heparin Blood-Thinner Meds Recalled (FindLaw’s Common Law Blog)
- Defective and Dangerous Products (FindLaw)
You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help
Civil Rights
Block on Trump’s Asylum Ban Upheld by Supreme Court
Criminal
Judges Can Release Secret Grand Jury Records
Politicians Can’t Block Voters on Facebook, Court Rules
